Precigen Achieves Significant Clinical Progress for UltraCAR-T® and AdenoVerse™ Therapies

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/3/2026

1. PANW
2. GTLB
3. MDB
4. DELL
5. GOOGL
6. VRTS
7. SPY
8. HPE
9. SNOW
10. USO

Go back to Precigen Achieves Significant Clinical Progress for UltraCAR-T® and AdenoVerse™ Therapies
(NASDAQ: PGEN) Delayed: 7.01 +0.15 (2.19%)
Previous Close $6.86    52 Week High $ 
Open $6.91    52 Week Low $ 
Day High $7.14    P/E N/A 
Day Low $6.82    EPS $ 
Volume 2,637,829